Proteases and antiproteases in ascites--differentiation of malignant and nonmalignant ascites and prediction of coagulopathy in ascites retransfusion.
Schölmerich
J
J
Department of Internal Medicine, University of Freiburg, FRG.
Köttgen
E
E
Volk
B A
BA
Gerok
W
W
D000990:Antithrombin III / Q000032:analysis; D001201:Ascites / Q000175:diagnosis* / Q000201:enzymology / Q000378:metabolism; D001778:Blood Coagulation Disorders / Q000175:diagnosis* / Q000188:drug therapy; D001798:Blood Proteins / Q000032:analysis; D003907:Dexamethasone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005353:Fibronectins / Q000032:analysis; D006801:Humans; D010447:Peptide Hydrolases / Q000378:metabolism*; D011480:Protease Inhibitors / Q000378:metabolism*; D000515:alpha 1-Antitrypsin
D001798:Blood Proteins; D005353:Fibronectins; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D003907:Dexamethasone; D000990:Antithrombin III; D010447:Peptide Hydrolases